Back to top

Analyst Blog

U.S. health insurer UnitedHealth Group Inc. (UNH - Analyst Report) reported first-quarter 2014 operating earnings of $1.10 per share, a penny ahead of the Zacks Consensus Estimate. However, earnings declined from $1.16 per share earned in the year-ago quarter.

Total revenue of $31.7 billion increased 5.0% year over year. However, the figure lagged the Zacks Consensus Estimate of $32.0 billion. The year-over-year increase in total revenue can primarily be attributed to an increase in people served in the public and senior markets at UnitedHealthcare as well as growth in Optum.

UnitedHealth improved its medical membership count by 6.3% year over year to 44.665 million as of March 31, 2014. Membership expansion was primarily driven by the TRICARE business. Other lines such as Medicare Advantage, Medicaid, Medicare Supplement and International also aided overall growth.

First-quarter medical care ratio decreased 20 basis points (bps) year over year to 82.5% and remained within the Obamacare mandated range of 80–85%.

Consolidated operating margin came in at 4.8%, down 90 bps from the year-ago quarter.    

Segment Details

The company’s UnitedHealthcare segment reported revenues of $29.3 billion, up 4% year over year, led by an increase in the number of people served across all medical benefit markets throughout the year.

Earnings from operations decreased 12.5% year over year to $1.4 billion. The decline stemmed from the effects of the ACA and Medicare sequestration. Also, a decline in the overall level of reserve development led to the fall in earnings from operations.  

Optum’s revenues of $11.2 billion rose 29% year over year, primarily on strong contribution from its sub-segments, Optum Rx, OptumHealth and OptumInsight. Earnings from operations grew 20% year over year to $650 million.

Financial Update

As of March 31, 2014, the debt-to-capital ratio of UnitedHealth stood at 34%, reflecting a 41 bps improvement from 34.4% as of Dec 31, 2013.

UnitedHealth released $1.4 billion of cash from operations at the end of the first quarter of 2014, up 33.7% year over year.  

Guidance Reaffirmation

UnitedHealth reiterated its 2014 revenue guidance of $128.0 billion to $129.0 billion and EPS projection of $5.40–$5.60.

Zacks Rank

UnitedHealth currently carries a Zacks Rank #3 (Hold). However, some better-ranked stocks in the industry are Aetna Inc. (AET - Analyst Report), WellPoint Inc. (WLP - Analyst Report) and MEDNAX, Inc. (MD - Snapshot Report). All three stocks carry a Zacks Rank #2 (Buy).
 

Read the Full Research Report on WLP
Read the Full Research Report on AET
Read the Full Research Report on UNH
Read the Full Research Report on MD


Zacks Investment Research

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.73 +5.07%
GREEN PLAIN… GPRE 45.56 +3.99%
WEATHERFORD… WFT 23.71 +3.38%
BANCO DO BR… BDORY 14.31 +2.54%
SUPER MICRO… SMCI 25.20 +2.02%